Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$8.63 - $12.56 $1,242 - $1,808
-144 Reduced 0.53%
27,236 $253,000
Q1 2024

May 14, 2024

BUY
$9.86 - $13.74 $269,966 - $376,201
27,380 New
27,380 $338,000
Q2 2023

Aug 14, 2023

BUY
$8.59 - $14.56 $2,147 - $3,640
250 Added 0.76%
33,330 $319,000
Q1 2023

May 10, 2023

BUY
$9.53 - $16.8 $202,102 - $356,277
21,207 Added 178.62%
33,080 $396,000
Q4 2022

Feb 14, 2023

SELL
$8.71 - $14.28 $15,991 - $26,218
-1,836 Reduced 13.39%
11,873 $165,000
Q3 2022

Nov 14, 2022

SELL
$7.19 - $9.91 $15,429 - $21,266
-2,146 Reduced 13.54%
13,709 $124,000
Q2 2022

Aug 11, 2022

BUY
$5.78 - $8.87 $91,641 - $140,633
15,855 New
15,855 $127,000

Others Institutions Holding ZYXI

About ZYNEX INC


  • Ticker ZYXI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Distribution
  • Shares Outstandng 37,453,400
  • Market Cap $313M
  • Description
  • Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and n...
More about ZYXI
Track This Portfolio

Track Alps Advisors Inc Portfolio

Follow Alps Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Alps Advisors Inc with notifications on news.